140 related articles for article (PubMed ID: 6290930)
41. Toxicity study of BCNU (NSC-409962) given orally.
Lessner HE; Vogler WR
Cancer Chemother Rep; 1974; 58(3):407-11. PubMed ID: 4601671
[No Abstract] [Full Text] [Related]
42. Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
Pouillart P; Mathe G; Thy TH; Lheritier J; Poisson M; Huguenin P; Gauthier H; Morin P; Parrot R
Cancer; 1976 Nov; 38(5):1909-16. PubMed ID: 1033028
[TBL] [Abstract][Full Text] [Related]
43. 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group.
Levin VA; Edwards MS; Wara WM; Allen J; Ortega J; Vestnys P
Neurosurgery; 1984 Jun; 14(6):679-81. PubMed ID: 6087193
[TBL] [Abstract][Full Text] [Related]
44. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
Dinapoli RP; Brown LD; Arusell RM; Earle JD; O'Fallon JR; Buckner JC; Scheithauer BW; Krook JE; Tschetter LK; Maier JA
J Clin Oncol; 1993 Jul; 11(7):1316-21. PubMed ID: 8315428
[TBL] [Abstract][Full Text] [Related]
45. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
Zackheim HS; Epstein EH
Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
[TBL] [Abstract][Full Text] [Related]
46. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
Moertel CG
Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
[No Abstract] [Full Text] [Related]
47. BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma.
Rege VB; Owens AH
Cancer Chemother Rep; 1974; 58(3):383-92. PubMed ID: 4601668
[No Abstract] [Full Text] [Related]
48. [CCNU in the chemotherapy of tumours of the central nervous system (author's transl)].
Adinolfi D; Pavesi L; Robustelli della Cuna G; Paoletti P
Riv Patol Nerv Ment; 1977; 98(3):191-5. PubMed ID: 616020
[TBL] [Abstract][Full Text] [Related]
49. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
50. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE
J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719
[TBL] [Abstract][Full Text] [Related]
51. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas.
Gururangan S; Cokgor L; Rich JN; Edwards S; Affronti ML; Quinn JA; Herndon JE; Provenzale JM; McLendon RE; Tourt-Uhlig S; Sampson JH; Stafford-Fox V; Zaknoen S; Early M; Friedman AH; Friedman HS
Neuro Oncol; 2001 Oct; 3(4):246-50. PubMed ID: 11584894
[TBL] [Abstract][Full Text] [Related]
52. Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.
Kim-Triana B; Misset JL; Madelmont JC; Godenèche D; Musset M; Mathé G
Anticancer Drugs; 1992 Jun; 3(3):225-31. PubMed ID: 1525402
[TBL] [Abstract][Full Text] [Related]
53. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
54. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
55. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
[TBL] [Abstract][Full Text] [Related]
56. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals.
Broder LE; Hansen HH
Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488
[No Abstract] [Full Text] [Related]
57. Development of second malignancies in rats after cure of acute leukemia L 5222 by single doses of 2-chloroethylnitrosoureas.
Zeller WJ; Schmähl D
J Cancer Res Clin Oncol; 1979 Sep; 95(1):83-6. PubMed ID: 227910
[TBL] [Abstract][Full Text] [Related]
58. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
[No Abstract] [Full Text] [Related]
59. Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs.
Kristal O; Rassnick KM; Gliatto JM; Northrup NC; Chretin JD; Morrison-Collister K; Cotter SM; Moore AS
J Vet Intern Med; 2004; 18(1):75-80. PubMed ID: 14765735
[TBL] [Abstract][Full Text] [Related]
60. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
